Patent details

Basic Information

Publication number:

EP3505186

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP182080325

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE

French Title of Invention:

CATALYSEURS NUCLÉOPHILES POUR LIAISON OXIME

German Title of Invention:

NUKLEOPHILE KATALYSATOREN FÜR OXIM-VERBINDUNG

SPC Number:

Dates

Filing date:

29/07/2011

Grant date:

12/01/2022

EP Publication Date:

03/07/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/01/2022

EP B1 Publication Date:

12/01/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/07/2022

Expiration date:

29/07/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/01/2022

 

 

Name:

Takeda Pharmaceutical Company Limited

Address:

1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka, Japan (JP)

Inventor

1

Name:

Ivens, Andreas

Address:

Switzerland (CH)

2

Name:

Turecek, Peter, Dr.

Address:

Austria (AT)

3

Name:

Rottensteiner, Hanspeter

Address:

Austria (AT)

4

Name:

Haider, Stefan

Address:

Austria (AT)

5

Name:

Siekmann, Jürgen, Dr.

Address:

Austria (AT)

6

Name:

Zoechling, Oliver

Address:

Austria (AT)

Priority

Priority Number:

36918610 P

Priority Date:

30/07/2010

Priority Country:

United States (US)

Classification

IPC classification:

A61K 47/60; A61K 47/61;

Publication

European Patent Bulletin

Issue number:

202202

Publication date:

12/01/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages